Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
QiJingShengBai Formula is a Traditional Chinese Medicine (TCM) herbal preparation developed by the Second Affiliated Hospital of Tianjin University of TCM. It is specifically designed to treat chemotherapy-induced leukopenia, a common side effect of cancer treatment characterized by a decrease in white blood cell counts. The formula typically incorporates herbs such as *Astragalus membranaceus* (Huangqi) and *Polygonatum sibiricum* (Huangjing), which are traditionally used to tonify "Qi" and "Jing" (essence) to support the body's hematopoietic and immune systems. It is currently being evaluated in real-world registration studies to establish standardized application methodologies and confirm its efficacy in mitigating hematological toxicity in cancer patients.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on QiJingShengBai Formula.